Enochian stock climbs on US patent for oncology platform

Oct. 17, 2022 1:40 PM ETEnochian Biosciences, Inc. (ENOB)By: Ravikash, SA News Editor

IP, Intellectual Property Patent Concept

Olivier Le Moal

  • Enochian BioSciences (NASDAQ:ENOB) stock rose ~5% on Monday after the company said that it received a U.S. patent for its proprietary cancer treatment platform which could potentially be used to induce life-long remission.
  • Preclinical animal and laboratory studies of

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.